| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/13/1994 | EP0605789A1 Characterization of oncogenes and assays based thereon |
| 07/13/1994 | EP0605680A1 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 07/13/1994 | EP0605653A1 A new form of liposaccharide binding protein (lbp) |
| 07/13/1994 | EP0605629A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 07/13/1994 | EP0605606A1 Diagnosing and treating autoimmune disorders |
| 07/13/1994 | EP0605522A1 Production of chimeric antibodies - a combinatorial approach |
| 07/13/1994 | EP0605442A1 Recombinant antibodies for human therapy |
| 07/13/1994 | EP0605432A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 07/13/1994 | EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
| 07/13/1994 | EP0309483B1 Production and use of anthelmintic agents and protective antigens |
| 07/13/1994 | CN1089303A Expression vectors and their use in the preparation of HIV-resistant human cells for therapeutic applications |
| 07/12/1994 | US5328996 DNA as anticoagulants |
| 07/12/1994 | US5328991 Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
| 07/12/1994 | US5328891 DNA codes and proteins |
| 07/12/1994 | US5328835 Expression of immunologically reactive HIV envelope proteins |
| 07/12/1994 | US5328688 Recombinant herpes simplex viruses vaccines and methods |
| 07/12/1994 | US5328470 Catheter |
| 07/07/1994 | WO1994014976A1 Immune response modulator complex, and uses thereof |
| 07/07/1994 | WO1994014974A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
| 07/07/1994 | WO1994014973A1 Novel neutrophil inhibitors |
| 07/07/1994 | WO1994014969A1 Novel proteinaceous particles |
| 07/07/1994 | WO1994014967A2 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same |
| 07/07/1994 | WO1994014962A1 Vaccines against varicella-zoster virus (vzv) |
| 07/07/1994 | WO1994014847A1 Genetically engineered immunoglobulins |
| 07/07/1994 | WO1994014846A1 Assay and treatment for demyelinating diseases such as multiple sclerosis |
| 07/07/1994 | WO1994014844A1 Bone resorption assay |
| 07/07/1994 | WO1994014475A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT |
| 07/07/1994 | WO1994014469A1 Multivalent ab1 antibodies as vaccines |
| 07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 07/07/1994 | WO1994014454A1 Vaccines against sterols |
| 07/07/1994 | WO1994014437A1 Prevention and treatment of sepsis |
| 07/07/1994 | WO1994014347A1 A protective garment |
| 07/07/1994 | WO1994014318A1 Method of protection against streptococcus pneumoniae with transformed mycobacteria |
| 07/07/1994 | WO1994011512A3 Allergenic proteins and peptides from japanese cedar pollen |
| 07/07/1994 | WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity |
| 07/07/1994 | WO1994010317A3 Conjugate vaccine against group b streptococcus |
| 07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
| 07/07/1994 | DE4244541A1 New HIV-type immune deficiency virus ECACC V 92092318 |
| 07/07/1994 | CA2152599A1 Novel neutrophil inhibitors |
| 07/07/1994 | CA2152256A1 Vaccines against varicella-zoster virus (vzv) |
| 07/07/1994 | CA2151386A1 Prevention and treatment of sepsis |
| 07/07/1994 | CA2127797A1 Monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus |
| 07/06/1994 | EP0605219A1 Products containing active milk protein components and process for producing the same |
| 07/06/1994 | EP0604727A1 Improved immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
| 07/06/1994 | EP0604647A1 Alleviation of symptoms associated with inflammatory disease states |
| 07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
| 07/06/1994 | EP0604603A1 Cadherin materials and methods |
| 07/06/1994 | EP0604566A1 Chimeric and/or growth-restricted flaviviruses |
| 07/06/1994 | EP0604488A1 Polypeptides, inhibitors of the replication of hsu and similar viruses |
| 07/06/1994 | EP0604453A1 Disease associated b-cell epitopes of tpo and use thereof |
| 07/06/1994 | EP0283505B1 Vaccine and method of preparation |
| 07/06/1994 | CN1088986A Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 07/06/1994 | CN1088936A Peg-interferon conjugates |
| 07/06/1994 | CN1025284C Birth control vaccine |
| 07/05/1994 | US5326856 Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| 07/05/1994 | US5326779 Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles |
| 07/05/1994 | CA1330529C Low molecular weight antiviral factors |
| 07/01/1994 | CA2112508A1 Immunogenicity of a vaccine by incorporation of a cytokine within an immune-stimulating complex containing an antigen |
| 06/29/1994 | EP0603992A1 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
| 06/29/1994 | EP0603615A2 Process of purification and enrichment of the Rubella Virus |
| 06/29/1994 | EP0603406A1 Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same |
| 06/29/1994 | EP0603386A1 Parenteral immunization against rotavirus |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
| 06/29/1994 | EP0354923B1 Method for labelling antibodies with a metal ion |
| 06/29/1994 | EP0245362B1 Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 06/28/1994 | US5324822 Cancer diagnosis |
| 06/28/1994 | US5324630 Methods and compositions for diagnosing lyme disease |
| 06/28/1994 | US5324628 Use of chymotrypsin for the inactivation of prekallikrein activator |
| 06/28/1994 | US5324614 Toner image removal fixed onto support |
| 06/28/1994 | US5324519 Biodegradable polymer composition |
| 06/28/1994 | US5324513 Composition useful for the fabrication of vaccines |
| 06/28/1994 | US5324512 [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
| 06/28/1994 | US5324511 Contain a single flagellar (H) antigen of serotype a or a combination with an antigen of serotype b; inhibit motility of pathogens |
| 06/28/1994 | CA1330425C Baculovirus expression system capable of producing foreign gene proteins at high levels |
| 06/26/1994 | CA2111999A1 Products containing active milk proteins and process for producing the same |
| 06/23/1994 | WO1994013836A1 Feline infectious peritonitis virus test utilizing monoclonal idiotypic and anti-idiotypic antibodies |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013815A1 Dna encoding chitin deacetylase |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013805A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 06/23/1994 | WO1994013801A1 Mammalian receptors for interleukin-10 (il-10) |
| 06/23/1994 | WO1994013795A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 06/23/1994 | WO1994013700A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994013699A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | WO1994013320A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 06/23/1994 | WO1994013264A1 Clostridial toxin disease therapy |
| 06/23/1994 | WO1994013253A1 Hair dye or cosmetic material, pretreatment agent and hair dyeing method |
| 06/23/1994 | CA2151257A1 Dna encoding chitin deacetylase |
| 06/23/1994 | CA2151128A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2151126A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 06/23/1994 | CA2150935A1 Clostridial toxin disease therapy |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2128544A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | CA2112046A1 Antibodies, polypeptides, production and use thereof |
| 06/23/1994 | CA2111998A1 Process for the purification and concentration of rubella virus |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |